These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 15037527)

  • 1. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
    Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
    Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
    Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
    Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
    Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
    Sasaki K; Heeschen C; Aicher A; Ziebart T; Honold J; Urbich C; Rossig L; Koehl U; Koyanagi M; Mohamed A; Brandes RP; Martin H; Zeiher AM; Dimmeler S
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14537-41. PubMed ID: 16983080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.
    Kissel CK; Lehmann R; Assmus B; Aicher A; Honold J; Fischer-Rasokat U; Heeschen C; Spyridopoulos I; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2007 Jun; 49(24):2341-9. PubMed ID: 17572250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease.
    Walter DH; Haendeler J; Reinhold J; Rochwalsky U; Seeger F; Honold J; Hoffmann J; Urbich C; Lehmann R; Arenzana-Seisdesdos F; Aicher A; Heeschen C; Fichtlscherer S; Zeiher AM; Dimmeler S
    Circ Res; 2005 Nov; 97(11):1142-51. PubMed ID: 16254213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
    Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
    Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
    Silvestre JS; Gojova A; Brun V; Potteaux S; Esposito B; Duriez M; Clergue M; Le Ricousse-Roussanne S; Barateau V; Merval R; Groux H; Tobelem G; Levy B; Tedgui A; Mallat Z
    Circulation; 2003 Dec; 108(23):2839-42. PubMed ID: 14656923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.
    Waeckel L; Mallat Z; Potteaux S; Combadière C; Clergue M; Duriez M; Bao L; Gerard C; Rollins BJ; Tedgui A; Levy BI; Silvestre JS
    Circ Res; 2005 Mar; 96(5):576-82. PubMed ID: 15718500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.
    Urbich C; Heeschen C; Aicher A; Dernbach E; Zeiher AM; Dimmeler S
    Circulation; 2003 Nov; 108(20):2511-6. PubMed ID: 14581410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
    Seeger FH; Rasper T; Koyanagi M; Fox H; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1802-9. PubMed ID: 19696399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
    Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
    Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response.
    Zen K; Okigaki M; Hosokawa Y; Adachi Y; Nozawa Y; Takamiya M; Tatsumi T; Urao N; Tateishi K; Takahashi T; Matsubara H
    J Mol Cell Cardiol; 2006 Jun; 40(6):799-809. PubMed ID: 16678200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
    Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
    J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease.
    Liguori A; Fiorito C; Balestrieri ML; Crimi E; Bruzzese G; Williams-Ignarro S; D'Amora M; Sommese L; Grimaldi V; Minucci PB; Giovane A; Farzati B; Ignarro LJ; Napoli C
    Eur J Haematol; 2008 Mar; 80(3):258-64. PubMed ID: 18081701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.